BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21488156)

  • 41. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.
    Oeffinger KC; Adams-Huet B; Victor RG; Church TS; Snell PG; Dunn AL; Eshelman-Kent DA; Ross R; Janiszewski PM; Turoff AJ; Brooks S; Vega GL
    J Clin Oncol; 2009 Aug; 27(22):3698-704. PubMed ID: 19564534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
    Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
    Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
    Ng K; Sargent DJ; Goldberg RM; Meyerhardt JA; Green EM; Pitot HC; Hollis BW; Pollak MN; Fuchs CS
    J Clin Oncol; 2011 Apr; 29(12):1599-606. PubMed ID: 21422438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia.
    Chang J; Douer D; Aldoss I; Vahdani G; Jeong AR; Ghaznavi Z; Zhang S; Yaghmour G; Lee KJ; Weissman A; Akhtari M
    Cancer Med; 2019 Jun; 8(6):2832-2839. PubMed ID: 31016870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study.
    Souberbielle JC; Massart C; Brailly-Tabard S; Cavalier E; Chanson P
    Endocrine; 2016 Aug; 53(2):543-50. PubMed ID: 27106800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
    Kato K; Yoshida N; Matsumoto K; Matsuyama T
    Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin D status in pediatric patients with a history of malignancy.
    Modan-Moses D; Pinhas-Hamiel O; Munitz-Shenkar D; Temam V; Kanety H; Toren A
    Pediatr Res; 2012 Dec; 72(6):620-4. PubMed ID: 23037871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Wofford MM; Smith SD; Shuster JJ; Johnson W; Buchanan GR; Wharam MD; Ritchey AK; Rosen D; Haggard ME; Golembe BL
    J Clin Oncol; 1992 Apr; 10(4):624-30. PubMed ID: 1548525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults.
    Eckard AR; Tangpricha V; Seydafkan S; O'Riordan MA; Storer N; Labbato D; McComsey GA
    Pediatr Infect Dis J; 2013 Nov; 32(11):1224-9. PubMed ID: 23360833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
    Fathi AT; DeAngelo DJ; Stevenson KE; Kolitz JE; Asch JD; Amrein PC; Attar EC; Steensma DP; Wadleigh M; Foster J; Connolly C; Galinsky I; Devoe CE; Stone RM; Neuberg DS; Ballen KK
    Cancer; 2016 Aug; 122(15):2379-88. PubMed ID: 27171984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia.
    Farag SS; Wood LL; Schwartz JE; Srivastava S; Nelson RP; Robertson MJ; Abonour R; Secrest A; Cox E; Baute J; Sullivan C; Kane K; Jones DR
    Leukemia; 2011 Apr; 25(4):599-605. PubMed ID: 21252987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
    Papayannidis C; Sartor C; Dominietto A; Zappone E; Arpinati M; Marconi G; Cristiano G; Nanni J; Parisi S; Barbato F; Paolini S; Soverini S; Terragna C; Robustelli V; Testoni N; Chirumbolo G; Curti A; Cavo M; Bonifazi F
    Hematol Oncol; 2021 Oct; 39(4):580-583. PubMed ID: 33963566
    [No Abstract]   [Full Text] [Related]  

  • 53. Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation Patients Despite Both Standard and Aggressive Supplementation.
    Wallace G; Jodele S; Myers KC; Dandoy CE; El-Bietar J; Nelson A; Taggart CB; Daniels P; Lane A; Howell J; Teusink-Cross A; Davies SM
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1271-1274. PubMed ID: 27044905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
    Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
    Rambaldi A; Ribera JM; Kantarjian HM; Dombret H; Ottmann OG; Stein AS; Tuglus CA; Zhao X; Kim C; Martinelli G
    Cancer; 2020 Jan; 126(2):304-310. PubMed ID: 31626339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between vitamin D deficiency, bone remodelling and iron status in iron-deficient young women consuming an iron-fortified food.
    Blanco-Rojo R; Pérez-Granados AM; Toxqui L; Zazo P; de la Piedra C; Vaquero MP
    Eur J Nutr; 2013 Mar; 52(2):695-703. PubMed ID: 22618893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D.
    Frisk P; Arvidson J; Ljunggren O; Gustafsson J
    Bone Marrow Transplant; 2012 May; 47(5):657-62. PubMed ID: 21765478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular dysfunction and vitamin D status in childhood acute lymphoblastic leukemia survivors.
    Muggeo P; Muggeo VMR; Giordano P; Delvecchio M; Altomare M; Novielli C; Ciccone MM; D'Amato G; Faienza MF; Santoro N
    World J Pediatr; 2019 Oct; 15(5):465-470. PubMed ID: 31055782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.
    Sebban C; Lepage E; Vernant JP; Gluckman E; Attal M; Reiffers J; Sutton L; Racadot E; Michallet M; Maraninchi D
    J Clin Oncol; 1994 Dec; 12(12):2580-7. PubMed ID: 7989932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.
    Kumar J; McDermott K; Abraham AG; Friedman LA; Johnson VL; Kaskel FJ; Furth SL; Warady BA; Portale AA; Melamed ML
    Pediatr Nephrol; 2016 Jan; 31(1):121-9. PubMed ID: 26307635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.